Marian Iwamoto
- Infectious Diseases top 0.5%
- Virology top 0.5%
- Molecular Biology
- Epidemiology top 5%
- Oncology top 10%
- Co-authors
- Larissa WenningJohn A. WagnerTatsuya KoikeYukio KatoJulie A. StoneFumihiko SuzukiY TakanoKeith Gottesdiener
- Topics
- HIV/AIDS drug development and treatment (61 papers)HIV Research and Treatment (32 papers)Hepatitis C virus research (18 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationNature Medicine
- Partner nations
- United StatesBelgiumJapan
In The Last Decade
Marian Iwamoto
107 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 108
- Infectious Diseases 1.7k
- Virology 1.1k
- Molecular Biology 681
- Epidemiology 531
- Oncology 406
Countries citing papers authored by Marian Iwamoto
This map shows the geographic impact of Marian Iwamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marian Iwamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marian Iwamoto more than expected).
Fields of papers citing papers by Marian Iwamoto
This network shows the impact of papers produced by Marian Iwamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marian Iwamoto. The network helps show where Marian Iwamoto may publish in the future.
Co-authorship network of co-authors of Marian Iwamoto
This figure shows the co-authorship network connecting the top 25 collaborators of Marian Iwamoto. A scholar is included among the top collaborators of Marian Iwamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marian Iwamoto. Marian Iwamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 7 | |
| 6 | 9 | |
| 7 | 50 | |
| 8 | 8 | |
| 9 | 10 | |
| 10 | 4 | |
| 11 | 58 | |
| 12 | 44 | |
| 13 | 35 | |
| 14 | Abstract #3604: A phase I single-rising dose study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of an oral akt inhibitor in healthy male volunteers | 4 |
| 15 | 76 | |
| 16 | Omeprazole Increases Plasma Levels of Raltegravir (RAL) in Healthy Subjects | 3 |
| 17 | 39 | |
| 18 | 134 | |
| 19 | 70 | |
| 20 | 75 |
About Marian Iwamoto
Marian Iwamoto is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 111 papers that have together received 2.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (61 papers), HIV Research and Treatment (32 papers) and Hepatitis C virus research (18 papers). The work is most often cited by research in Virology (1.1k citations), Infectious Diseases (1.7k citations) and Emergency Medicine (276 citations). Marian Iwamoto has collaborated with scholars based in United States, Belgium and Japan. Frequent co-authors include Larissa Wenning, John A. Wagner, Tatsuya Koike, Yukio Kato, Julie A. Stone, Fumihiko Suzuki, Y Takano, Keith Gottesdiener, Evan Friedman and S. Aubrey Stoch. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.